125 related articles for article (PubMed ID: 36241221)
21. Estimates of the global burden of cervical cancer associated with HIV.
Stelzle D; Tanaka LF; Lee KK; Ibrahim Khalil A; Baussano I; Shah ASV; McAllister DA; Gottlieb SL; Klug SJ; Winkler AS; Bray F; Baggaley R; Clifford GM; Broutet N; Dalal S
Lancet Glob Health; 2021 Feb; 9(2):e161-e169. PubMed ID: 33212031
[TBL] [Abstract][Full Text] [Related]
22. Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems.
Shin W; Ham TY; Park YR; Lim MC; Won YJ
Sci Rep; 2021 Mar; 11(1):6988. PubMed ID: 33772044
[TBL] [Abstract][Full Text] [Related]
23. Global estimates of HIV infections and AIDS cases: 1991.
Chin J
AIDS; 1991; 5 Suppl 2():S57-61. PubMed ID: 1845061
[TBL] [Abstract][Full Text] [Related]
24. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
[TBL] [Abstract][Full Text] [Related]
25. Association between definitive chemoradiotherapy wait-time and survival in locally-advanced cervical cancer: Implications during the coronavirus pandemic.
Matsuo K; Huang Y; Matsuzaki S; Ragab OM; Roman LD; Wright JD
Gynecol Oncol; 2021 May; 161(2):414-421. PubMed ID: 33771396
[TBL] [Abstract][Full Text] [Related]
26. Geographic considerations of endometrial cancer.
Dunn JE
Gynecol Oncol; 1974 Aug; 2(2-3):114-21. PubMed ID: 4457397
[TBL] [Abstract][Full Text] [Related]
27. Radical radiotherapy in patients with cervix uteri carcinoma: experience of Ondokuz Mayis University.
Serarslan A; Gursel B; Meydan D; Ozbek Okumus N
BMC Cancer; 2019 Dec; 19(1):1208. PubMed ID: 31830953
[TBL] [Abstract][Full Text] [Related]
28. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy.
Lee LJ; Das IJ; Higgins SA; Jhingran A; Small W; Thomadsen B; Viswanathan AN; Wolfson A; Eifel P;
Brachytherapy; 2012; 11(1):53-7. PubMed ID: 22265438
[TBL] [Abstract][Full Text] [Related]
29. Cervical carcinoma in Surinam. Incidence and staging of cervical carcinoma between 1989 and 1994.
Krul EJ; Peters LA; Vandenbroucke JP; Vrede A; van Kanten RW; Fleuren GJ
Cancer; 1996 Apr; 77(7):1329-33. PubMed ID: 8608511
[TBL] [Abstract][Full Text] [Related]
30. Laparoscopic surgical staging of locally advanced cervix cancer (IB2 to IVA): initial experience.
Zanvettor PH; Filho DF; Neves AR; Amorim MJ; Medeiros SM; Laranjeiras LC; Morais JA; Araujo IO; Barbosa HS
Gynecol Oncol; 2011 Mar; 120(3):358-61. PubMed ID: 21237504
[TBL] [Abstract][Full Text] [Related]
31. Geographical pathology of cancer of the uterine cervix.
Persaud V
Trop Geogr Med; 1977 Dec; 29(4):335-45. PubMed ID: 610015
[TBL] [Abstract][Full Text] [Related]
32. Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
Alimena S; Yang DD; Melamed A; Mahal BA; Worley MJ; Feldman S; Elias KM; Orio PF; Lee LJ; King M
Gynecol Oncol; 2019 Sep; 154(3):595-601. PubMed ID: 31292103
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
[TBL] [Abstract][Full Text] [Related]
34. Srinagarind Hospital experience in concurrent chemoradiation for 100 patients with stage IB2 to IVA uterine cervical cancer.
Tangsiriwatthana T; Chumworathayi B; Yuenyao P; Luanratanakorn S; Pattamadilok J
Radiat Med; 2007 Dec; 25(10):502-10. PubMed ID: 18085400
[TBL] [Abstract][Full Text] [Related]
35. Treatment of pre- and confirmed cervical cancer in HIV-seropositive women from developing countries: a systematic review.
Mapanga W; Singh E; Feresu SA; Girdler-Brown B
Syst Rev; 2020 Apr; 9(1):79. PubMed ID: 32276672
[TBL] [Abstract][Full Text] [Related]
36. Sentinel node biopsy is reliable in early-stage cervical cancer but not in locally advanced disease.
Barranger E; Coutant C; Cortez A; Uzan S; Darai E
Ann Oncol; 2005 Aug; 16(8):1237-42. PubMed ID: 15890666
[TBL] [Abstract][Full Text] [Related]
37. Cervical cancer in Africa, Latin America and the Caribbean and Asia: Regional inequalities and changing trends.
Vaccarella S; Laversanne M; Ferlay J; Bray F
Int J Cancer; 2017 Nov; 141(10):1997-2001. PubMed ID: 28734013
[TBL] [Abstract][Full Text] [Related]
38. Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer.
Kim JY; Byun SJ; Kim YS; Nam JH
Gynecol Oncol; 2017 Jan; 144(1):34-39. PubMed ID: 27789082
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.
Ogembo RK; Gona PN; Seymour AJ; Park HS; Bain PA; Maranda L; Ogembo JG
PLoS One; 2015; 10(4):e0122488. PubMed ID: 25875167
[TBL] [Abstract][Full Text] [Related]
40. Pretreatment retroperitoneal para-aortic lymph node staging in advanced cervical cancer: a review.
Smits RM; Zusterzeel PL; Bekkers RL
Int J Gynecol Cancer; 2014 Jul; 24(6):973-83. PubMed ID: 24978708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
